EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dominant Follicle Size as a Predictor of Pregnancy in Letrozole Intrauterine Insemination

Emel Özalp iD, Belgin Savran Üçok, Türkan Dikici Aktaş, Recep Taha Ağaoğlu iD, Özgür Volkan Akbulut, Kubilay Çanga iD, İnci Kahyaoğlu

Journal of Clinical Medicine · 27.07.2026 · 15 (15) · 5857

DOI: 10.3390/jcm15155857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.07.2026. Verfasst von Emel Özalp und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ministry of Health, Ankara Etlik City Hospital, 06170 Ankara, Turkey. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Letrozole combined with intrauterine insemination (IUI) is a common first-line treatment for unexplained and anovulatory infertility; however, the optimal dominant follicle size at human chorionic gonadotrophin (hCG) triggering remains uncertain. We evaluated associations of follicle size with biochemical pregnancy, clinical pregnancy, and live birth.

Methods

This retrospective cohort included 596 letrozole–IUI cycles from 454 women aged 21.0 mm). Mixed-effects logistic regression accounted for repeated cycles.

Results

Biochemical pregnancy, clinical pregnancy, and live-birth rates differed across groups and were highest at 19.0–21.0 mm; live-birth rates were 3.4%, 15.1%, and 8.6%, respectively (p = 0.008). Compared with 17.0–18.9 mm, the 19.0–21.0 mm group had higher adjusted odds of clinical pregnancy (aOR 5.58, 95% CI 1.31–23.84; p = 0.020) and live birth (aOR 15.15, 95% CI 1.74–131.95; p = 0.014), although both estimates were imprecise. Adjusted live-birth probabilities were 3.5%, 16.1%, and 9.1%, respectively. The direction of the live-birth association was preserved in the single-cycle sensitivity analysis (aOR 3.85, 95% CI 1.22–12.13; p = 0.021). Continuous linear and quadratic follicle-diameter models were not significant.

Conclusions

The 19.0–21.0 mm category was associated with higher reproductive outcome rates, including live birth; however, the observational design, sparse events, wide confidence intervals, and null continuous analyses preclude defining an optimal trigger threshold. These findings are hypothesis-generating and require prospective multicenter confirmation.

Schlagwörter

Stichwörter der Autor:innen

aromatase inhibitorfolliculometryovarian stimulationpolycystic ovary syndromesubfertilityunexplained infertility

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Ministry of Health, Ankara Etlik City Hospital, 06170 Ankara, Turkey.

ORCID-Profile: Emel Özalp, Recep Taha Ağaoğlu, Kubilay Çanga

Zitieren

APA

Özalp, E., Savran Üçok, B., Dikici Aktaş, T., Ağaoğlu, R. T., Akbulut, Ö. V., Çanga, K., & Kahyaoğlu, İ. (2026). Dominant Follicle Size as a Predictor of Pregnancy in Letrozole Intrauterine Insemination. Journal of Clinical Medicine, 15(15), 5857. https://doi.org/10.3390/jcm15155857

Vancouver

Özalp E, Savran Üçok B, Dikici Aktaş T, Ağaoğlu RT, Akbulut ÖV, Çanga K, et al. Dominant Follicle Size as a Predictor of Pregnancy in Letrozole Intrauterine Insemination. Journal of Clinical Medicine. 2026;15(15):5857. doi:10.3390/jcm15155857

BibTeX
@article{zalp2026,
  author = {Özalp, Emel and Savran Üçok, Belgin and Dikici Aktaş, Türkan and Ağaoğlu, Recep Taha and Akbulut, Özgür Volkan and Çanga, Kubilay and Kahyaoğlu, İnci},
  title = {Dominant Follicle Size as a Predictor of Pregnancy in Letrozole Intrauterine Insemination},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {5857},
  doi = {10.3390/jcm15155857}
}
Kostenlos starten →